EPLAW PATENT BLOG

EU – General Court partially annuls EC’s decision on restrictive agreements and abuse of dominant positionon the market for perindopril

Posted: December 13th, 2018

Judgments in Cases T-677/14 Biogaran v. Commission, T-679/14 Teva UK and Others v. Commission, T680/14 Lupin v. Commission, T-682/14 Mylan Laboratories and Mylan v. Commission, T-684/14 Krka v. Commission, T-701/14 Niche Generics v. Commission, T-705/14 Unichem Laboratories v. Commission, T-691/14 Servier and Others v. Commission, General Court of the European Union, Luxembourg, 12 December 2018 […]

READ MORE

UK – Unwired Planet International Ltd v. Huawei

Posted: November 1st, 2018

Unwired Planet International Ltd v Huawei Technologies Co Ltd, Court of Appeal, London, UK [2018] EWCA Civ 2344 On 23 October 2018, the Court of Appeal handed down its judgment in Unwired Planet v Huawei on FRAND licensing of standard-essential patents (‘SEPs’). The Court of Appeal dismissed all three grounds of Huawei’s appeal and upheld […]

READ MORE

NL – Nikon v. ASML / Case No. 1

Posted: July 23rd, 2018

Nikon Corporation v. ASML Holding N.V., ASML Netherlands B.V. and ASML Systems B.V., District Court of The Hague, 18 July 2018, Case No. ECLI:NL:RBDHA:2018:8777 This is case no. 1 of 11 patent cases between Nikon and ASML. Lithography machines are used in the production of chips. Nikon holds EP 1 652 003 (‘EP 003) relating […]

READ MORE

UK – Q Delta v Zyxel / “external eyes only” confidentiality regime

Posted: July 16th, 2018

UK Court clarifies applicability of “external eyes only” confidentiality regime The issue whether certain licence agreements should only be disclosed on an “external eyes only” basis, i.e. only to external solicitors, counsel and independent experts, was recently decided in the UK by Carr J in the TQ Delta v Zyxel case. The case involved inter […]

READ MORE

DE – Confidentiality roulette in SEP proceedings

Posted: May 30th, 2018

Confidentiality roulette in SEP infringement proceedings, by Alexander Haertel and Jonas Block, Kather Augenstein On 25 April 2018 the Higher Regional Court of Düsseldorf has continued its elaborated case-law with regard to confidentiality arrangements in standard essential patent (SEP) litigation (I-2 W 8/18). The Court deepened its transparency-approach taken already in a decision in January […]

READ MORE

UK – Conversant Wireless v Huawei Technologies and  ZTE Corporation / FRAND

Posted: April 20th, 2018

Conversant Wireless Licensing S.A.R,L v (1) Huawei Technologies Co. Ltd., (2) Huawei Technologies (UK) Co. Ltd, (3) ZTE Corporation (4) ZTE (UK) Limited, High Court of Justice, London, UK, 16 April 2018, [2018] EWHC 808 (Pat) Are the UK Courts an appropriate forum for hearing a global FRAND dispute where alleged infringement of Chinese patents […]

READ MORE

EU – Commission to set out EU approach to SEPs

Posted: December 8th, 2017

Communication from the Commission to the Institutions on Setting out the EU approach to Standard Essential Patents “In view of current developments, the Commission considers that SEP licencing should be based on the basis of the following principles: – There is no one-size-fit-all solution on what FRAND is: what can be considered fair and reasonable […]

READ MORE

FR – Core v. LG

Posted: May 12th, 2017

Core Wireless Licensing (“Core”) asserted five patents related to UTMS, GSM, GPRS, EGPRS and LTE against LG Electronics France (“LGEF”) and LG Electronics Inc. (“LGEI”). In a ruling dated 17 April 2015, the Paris Court of First Instance ruled that none of the patents were essential to the standards and dismissed Core’s claims. In a […]

READ MORE

NL – Sun v. Novartis / Supreme Court

Posted: May 8th, 2017

Sun Pharmaceutical Industries (Europe) B.V. v. Novartis AG, Supreme Court of the Netherlands, 14 April 2017, Case No. ECLI:NL:HR:2017:692 Preliminary injunction proceedings. Patent for second medical indication. Swiss-type claim. Novartis owns EP 1 296 689 with a Swiss type claim for use of zoledronic acid in the preparation of a medicament for the treatment of […]

READ MORE